OptimizeRx (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility that was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction.
This financing is significant for OptimizeRx as it provides the company with additional capital to support its growth strategy. The company specializes in connecting life science brands with patients and healthcare providers through a platform that combines innovative artificial intelligence (AI)-driven tools, including the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT). These tools enable hyper-local engagement and synchronized marketing solutions that aim to drive faster treatment decisions and improve patient outcomes.
The credit facility strengthens OptimizeRx's balance sheet and provides financial flexibility to pursue strategic initiatives, such as potential acquisitions, product development, or expansion of its technology platform. For the healthcare technology industry, this move signals OptimizeRx's commitment to scaling its operations and enhancing its competitive position in the market.
OptimizeRx's focus on privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact. The company partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape. Headquartered in Waltham, Massachusetts, OptimizeRx is redefining how life science brands engage with patients and healthcare providers.
The announcement is particularly relevant for investors and stakeholders in the healthcare technology sector, as it demonstrates the company's ability to secure financing from a major bank like Fifth Third Bank. This may indicate confidence in OptimizeRx's business model and growth prospects. The undrawn revolving credit facility also provides a cushion for future capital needs without immediate dilution for shareholders.
To view the full announcement, visit https://ibn.fm/G0Fj3. For more information about OptimizeRx, visit www.optimizerx.com.
